GRI Bio, Inc.
GRI Bio, Inc. (GRI) Revenue
Annual & quarterly revenue history · segment & region breakdown
GRI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGRI Bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.02B | -100.00% |
| 2024-12-31 | $0.02B | +$0.02B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | -$0.00B | -100.00% |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income GRI Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
GRI Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from GRI Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GRI revenue · 4 questionsGRI's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · GRI Bio, Inc. SEC filings · GAAP · GRI Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026